Valion Bio, Inc.
Valion Bio develops biologics that activate innate immune pathways for cytoprotection and immune modulation.
8-KNov 16Latest SEC filing
Nov 16Latest story
November 2026
October 2026
September 2026
August 2026
July 2026
Valion Bio develops biologics that activate innate immune pathways for cytoprotection and immune modulation.
November 2026
October 2026
September 2026
August 2026
July 2026